(Q35411830)

8 August 2017

1 reference

title

The halogenated 8-hydroxyquinolines (English)

1 reference

8 August 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1977.TB04317.X

13 December 2022

author name string

K. H. Neldner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A140848

13 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=140848

13 December 2022

publication date

1 May 1977

1 reference

full work available at URL

8 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-4362.1977.tb04317.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1977.TB04317.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-4362.1977.tb04317.x/fullpdf

13 December 2022

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1977.TB04317.X

International Journal of Dermatology

13 December 2022

published in

1 reference

8 August 2017

volume

16

1 reference

8 August 2017

issue

4

1 reference

8 August 2017

page(s)

267-273

1 reference

Neurological syndrome associated with clioquinol

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1977.TB04317.X

Experimental myelo-optic neuropathy induced by clioquinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1977.TB04317.X

Proceedings of the Society for Experimental Biology and Medicine

21 January 2018

2

28

828

Anderson H. H.

1931

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1977.TB04317.X

PROPHYLAXIS AND THERAPY OF AMEBIASIS AND SHIGELLOSIS WITH IODOCHLORHYDROXYQUIN.

13 December 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1977.TB04317.X

The physiological disposition of diodoquin, vioform, and chiniofon in the rabbit as determined with radioiodine

13 December 2022

6

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1977.TB04317.X

On 8-Hydroxyquinoline-Zinc Oxide Incompatibility

13 December 2022

8

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1977.TB04317.X

The neurotoxicity of the halogenated hydroxyquinolines. A commentary

13 December 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1977.TB04317.X

Entero-Vioform in travelers' diarrhea

13 December 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1977.TB04317.X

Chemoprophylaxis of diarrhea

13 December 2022

16

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1977.TB04317.X

Toxic damage to the optic nerve caused by iodochlorhydroxyquinoline (enterovioform).

13 December 2022

17

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1977.TB04317.X

Letter: Acrodermatitis enteropathica: a lethal inherited human zinc-deficiency disorder

13 December 2022

20

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1977.TB04317.X

Zinc Therapy of Acrodermatitis Enteropathica

13 December 2022

21

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1977.TB04317.X

Acrodermatitis enteropathica: report of three new cases

13 December 2022

25

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1977.TB04317.X

Determination of oxyquinoline concentrations in plasma in a patient treated for acrodermatitis enteropathica--an aid in therapeutic control

13 December 2022

29

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1977.TB04317.X

Amaurosis after broxyquinoline

13 December 2022

32

1 reference

https://api.crossref.org/works/10.1111/J.1365-4362.1977.TB04317.X

13 December 2022

Identifiers

1 reference

8 August 2017

1 reference